MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

31 hedge funds and large institutions have $52.2M invested in Marinus Pharmaceuticals, Inc in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.51M
2
+$492K
3
+$372K
4
UOC
UBS O'Connor
Illinois
+$123K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$89K

Top Sellers

1
-$1.56M
2
-$1.53M
3
-$1.48M
4
CS
Credit Suisse
Switzerland
-$280K
5
NC
Nexthera Capital
New York
-$191K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6K
27
$5K
28
$3K
29
$2K
30
$1K
31
$279
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
1
2